Related Experiment Videos
Strategies for tumor immune escape
Lorenzo Piemonti1, Alessandro Zerbi, Valerio Di Carlo
1Laboratory of Experimental Surgery, Department of Surgery II, Fondazione Centro S. Raffaele del Monte Tabor, Milan, Italy. piemonti.lorenzo@hsr.it
Drugs of Today (Barcelona, Spain : 1998)
|October 31, 2003
Summary
Tumors interact with the immune system during cancer development. This review explores how malignant cells evade immune responses, a key factor in tumor progression and immune evasion strategies.
Area of Science:
- Immunology
- Oncology
- Cancer Biology
Background:
- Malignant cells interact with the host immune system during tumorigenesis.
- Tumors possess immunogenic properties, expressing antigens recognized by the immune system.
- Despite immunogenicity, tumors frequently evade immune surveillance, leading to progression.
Purpose of the Study:
- To review and evaluate current knowledge on tumor-immune interactions.
- To analyze the diverse strategies employed by tumors to escape immune responses.
- To understand the mechanisms of immune evasion in cancer progression.
Main Methods:
- Literature review of scientific publications on tumor immunology and cancer evasion.
- Synthesis of current research findings on tumor-escape mechanisms.
- Evaluation of evidence for various immune evasion strategies.
Main Results:
- Tumors evolve variants that evade immune detection.
- Malignant cells develop strategies to avoid immune control and surveillance.
- Immune evasion is a critical factor in tumor progression.
Conclusions:
- Understanding tumor-immune interactions is crucial for cancer therapy.
- Identifying tumor-escape strategies can lead to novel immunotherapeutic approaches.
- Further research into immune evasion mechanisms is warranted.